Growing a Forward-Thinking CDMO

May 4, 2022 PAO-04-22-R250-78

On another Road to 50 States visit, Hank Nowak, Executive Director and Head of Global Business Development and Marketing at CoreRx, talks to Nigel about how the financial support from NovaQuest Capital Management’s acquisition of CoreRx has helped the company continue to grow and invest from 2021 into 2022.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

CoreRx

CoreRx is a forward-thinking and forward-acting Contract Development and Manufacturing Organization.


CoreRx provides innovative drug formulation, development, GMP manufacturing and packaging solutions to global pharmaceutical and bio-pharmaceutical partners. From state-of-the-art facilities in Clearwater, Florida and San Rafael, California, CoreRx supports, enhances and accelerates drug programs from clinical to commercial scale.

Q: